Vyawhare NA. An FMEA-driven holistic approach to quality risk management for new product introduction in pharmaceutical commercial plant: navigating global regulatory landscapes. Int. J. Res. Pharm. Sci. [Internet]. 2025 Aug. 6 [cited 2025 Oct. 9];16(3):24-45. Available from: https://ijrps.com/home/article/view/4788